Capital Fund Management (CFM)
REGN icon

Capital Fund Management (CFM)’s Regeneron Pharmaceuticals REGN Stock Holding History

Capital Fund Management (CFM)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,834
Closed -$40M – 2607
2025
Q3 		$33.1M Sell
58,834
-14,043
-19% -$7.94M 0.09% 319
2025
Q2 		$38.3M Sell
72,877
-19,933
-21% -$11.1M 0.11% 277
2025
Q1 		$58.9M Buy
92,810
+35,855
+63% +$24.7M 0.17% 166
2024
Q4 		$40.6M Buy
56,955
+40,073
+237% +$33.6M 0.1% 280
2024
Q3 		$17.7M Buy
16,882
+5,031
+42% +$5.6M 0.05% 498
2024
Q2 		$12.5M Sell
11,851
-2,096
-15% -$2.03M 0.04% 583
2024
Q1 		$13.4M Buy
+13,947
New +$13.3M 0.04% 598
2022
Q3 		– Sell
-25,054
Closed -$14.8M – 1612
2022
Q2 		$14.8M Buy
+25,054
New +$16.3M 0.13% 202
2021
Q4 		– Sell
-11,722
Closed -$7.09M – 1800
2021
Q3 		$7.09M Sell
11,722
-4,908
-30% -$3.05M 0.05% 470
2021
Q2 		$9.29M Buy
+16,630
New +$8.43M 0.07% 357
2019
Q3 		– Sell
-25,618
Closed -$7.58M – 1849
2019
Q2 		$8.02M Buy
25,618
+22,171
+643% +$7.38M 0.07% 367
2019
Q1 		$1.42M Buy
+3,447
New +$1.42M 0.01% 927
2017
Q2 		– Sell
-5,600
Closed -$2.45M – 1680
2017
Q1 		$2.17M Buy
+5,600
New +$2.08M 0.02% 705
2016
Q4 		– Sell
-3,866
Closed -$1.47M – 1825
2016
Q3 		$1.55M Sell
3,866
-743
-16% -$298K 0.01% 833
2016
Q2 		$1.61M Buy
+4,609
New +$1.78M 0.02% 801
2016
Q1 		– Sell
-8,757
Closed -$3.61M – 1787
2015
Q4 		$4.75M Buy
8,757
+2,063
+31% +$1.12M 0.05% 453
2015
Q3 		$3.11M Buy
+6,694
New +$3.59M 0.03% 501
2014
Q2 		– Sell
-6,495
Closed -$1.92M – 1883
2014
Q1 		$1.95M Buy
+6,495
New +$2M 0.02% 698

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital Fund Management (CFM)'s REGN Position: Q4 2025 in Review

Capital Fund Management (CFM) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 58,834 shares — an estimated $40M sold.

Capital Fund Management (CFM) first reported a position in REGN in Q1 2014 and held it in 18 quarters. The position peaked at $58.9M in Q1 2025. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Capital Fund Management (CFM) reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 58,834 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $40M.
  • Capital Fund Management (CFM) first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Capital Fund Management (CFM)'s Regeneron Pharmaceuticals position peaked at $58.9M in Q1 2025.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2025, filed 17 Feb 2026.